专利信息

查询条件展开筛选条件

[专利权人] 包含 'AVENTIS PHARMA SA [FR]'

[药品] 包含 'Irinotecan '

首页 1 尾页共 10 条记录, 当前第1/1页。

	公开号	公开日	申请号	申请日

首页 1 尾页共 10 条记录, 当前第1/1页。

当前查询条件: [专利权人] 包含 'AVENTIS PHARMA SA [FR]' AND [药品] 包含 'Irinotecan '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. RS51777B	2011/12/31	RSP20110215	2008/7/2
专利标题：ANTITUMOR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN 专利权人：AVENTIS PHARMA SA [FR];

2. US2010160233A1	2010/6/24	US20100651767	2010/1/4
专利标题：ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN 专利权人：AVENTIS PHARMA SA [FR]; Disclosed are antitumor combinations of VEGF inhibitors with Irinotecan and the use thereof in the treatment of neoplastic diseases.

3. EP2173349A2	2010/4/14	EP20080827826	2008/7/2
专利标题：ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN 专利权人：AVENTIS PHARMA SA [FR];

4. KR20100031123A	2010/3/19	KR20107000011	2008/7/2
专利标题：ANTITUMOR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN 专利权人：AVENTIS PHARMA SA [FR]; Antitumour combinations of VEGF inhibitors with Irinotecan of therapeutic use in the treatment of neoplastic diseases.

5. MX2009013950A	2010/3/9	MX20090013950	2009/12/17
专利标题：ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN. 专利权人：AVENTIS PHARMA SA [FR]; Antitumour combinations of VEGF inhibitors with Irinotecan of therapeutic use in the treatment of neoplastic diseases.

6. WO2009024667A2	2009/2/26	WO2008FR00943	2008/7/2
专利标题：ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN 专利权人：AVENTIS PHARMA SA [FR];BISSERY MARIE-CHRISTINE [FR];CHIRON-BLONDEL MARIELLE [FR];LEJEUNE PASCALE [FR];VRIGNAUD PATRICIA [FR]; Antitumour combinations of VEGF inhibitors with Irinotecan of therapeutic use in the treatment of neoplastic diseases.

7. CA2693152A1	2009/2/26	CA20082693152	2008/7/2
专利标题：ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN 专利权人：AVENTIS PHARMA SA [FR]; Combinaisons antitumorales constitu?es d'inhibiteur de VEGF associ?s ? l'irinotecan th?rapeutiquement utiles dans le traitement des maladies n?oplastiques.

8. US6476043B1	2002/11/5	US20010762092	2001/3/21
专利标题：Use of camptothecin derivatives, with reduced gastrointestinal toxicity 专利权人：AVENTIS PHARMA SA [FR]; Use of sodium chloride for preparing an agent intended to reduce or eliminate the gastrointestinal side effects induced by the administration of camptothecin derivatives, characterized in that the sodium chloride solution is administered orally.

9. EP1140073A1	2001/10/10	EP19990961114	1999/12/20
专利标题：COMBINATIONS OF FARNESYL TRANSFERASE INHIBITORS AND IRINOTECAN OR CAMPTOTHECIN FOR TREATING CANCER 专利权人：AVENTIS PHARMA SA [FR];

10. WO0037076A1	2000/6/29	WO1999FR03207	1999/12/20
专利标题：COMBINATIONS OF FARNESYL TRANSFERASE INHIBITORS AND IRINOTECAN OR CAMPTOTHECIN FOR TREATING CANCER 专利权人：AVENTIS PHARMA SA [FR]; The invention concerns combinations containing at least a farnesyl transferase inhibitor and at least a topoisomerase inhibitor.

下载范围

下载内容